Bret Christensen - 01 Apr 2026 Form 4 Insider Report for biote Corp. (BTMD)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: BTMD
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Apr 2026, 13:25:45 UTC
Prior SEC filing: 18 Mar 2025
Next SEC filing: 10 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kendal McNeely, as Attorney-in-Fact for Bret Christensen

Key filing fact

Bret Christensen filed Form 4 for biote Corp. (BTMD) on 03 Apr 2026.

Key facts

This page summarizes Bret Christensen's Form 4 filing for biote Corp. (BTMD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Apr 2026, 13:25.

Change

Previous filing in this sequence was filed on 18 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001707443 Primary reporting owner

Christensen Bret

Relationship: Chief Executive Officer, Director
Address: C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING
Signature: /s/ Kendal McNeely, as Attorney-in-Fact for Bret Christensen
Signature date: 03 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BTMD transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares: +441,653
Change %
Price: $0.000000^*
Shares after: 441,653
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 441,653
Exercise price: $1.43
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares subject to the option shall vest on April 1, 2027, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.